Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2014 October;66(5) > Minerva Pediatrica 2014 October;66(5):491-500

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532


eTOC

 

  PEDIATRIC GASTROENTEROLOGY


Minerva Pediatrica 2014 October;66(5):491-500

language: English

The use of probiotics in IBD and IBS

De Greef E., Vandenplas Y., Hauser B., Devreker T., Veereman G.

Pediatric Gastroenterology, UZ Brussel, Belgium


PDF  


While the role of microflora is well established in the development of inflammatory bowel disease (IBS); data is still emerging regarding IBS as the knowledge on brain-gut interaction grows. For both patient groups multiple efficacious treatments exist, but there are still unmet needs as long term disease control remains an issue. Given the importance of the microbiome on the development of the immune system and the interaction between the microbiome and the host organism, this “route” is being examined increasingly as a therapeutic possibility in both pathologies with variable results. We here provide a short overview on the existing data, meta-analysis and single studies, on probiotic treatment in both diseases.

top of page

Publication History

Cite this article as

Corresponding author e-mail

degreefelisabeth@gmail.com